Almac and Illumina partner on next-gen in vitro assays

By Fiona BARRY

- Last updated on GMT

Almac Diagnostics is part of Almac Group
Almac Diagnostics is part of Almac Group

Related tags Partnership

Northern Ireland CDMO Almac is working with US gene testing company Illumina to create next-generation sequencing diagnostic assays.

The collaboration will use Illumina’s MiSeqDx tool, the first in vitro diagnostic next-generation sequencing (NGS) system to be approved by the FDA for clinical lab use. Almac Diagnostics, a daughter company of Almac Group, will contribute experience in developing multiplex RNA- and DNA-based tests from its current companion diagnostic partnerships with big pharma.

Almac said the partnership will allow it to offer a greater range of complex assays to its customers.

We are extremely pleased to announce this collaboration with Illumina​,” said Almac Diagnostics president and managing director Paul Harkin. “We are fully committed to the development of precision medicine and partnerships of this nature provide more avenues for test delivery, enabling development of diagnostic tests which will ultimately improve care in a wide range of disease areas.​”

Almac announced this week it is expanding its contract development footprint​ to Loughborough, England and hiring 180 people to run labs at AstraZeneca’s old process development site.

Related news

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars